93 related articles for article (PubMed ID: 9793650)
1. Tissue quality is an important determinant of telomerase activity as measured by TRAP assay.
Yan P; Bosman FT; Benhattar J
Biotechniques; 1998 Oct; 25(4):660-2. PubMed ID: 9793650
[No Abstract] [Full Text] [Related]
2. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).
Kim NW; Wu F
Nucleic Acids Res; 1997 Jul; 25(13):2595-7. PubMed ID: 9185569
[TBL] [Abstract][Full Text] [Related]
3. Detection of telomerase activity in Plasmodium falciparum using a nonradioactive method.
Rubiano CC; Wasserman M
Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):693-5. PubMed ID: 12973539
[TBL] [Abstract][Full Text] [Related]
4. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity.
Wright WE; Shay JW; Piatyszek MA
Nucleic Acids Res; 1995 Sep; 23(18):3794-5. PubMed ID: 7479015
[No Abstract] [Full Text] [Related]
5. Detection of telomerase activity in high concentration of cell lysates using primer-modified gold nanoparticles.
Xiao Y; Dane KY; Uzawa T; Csordas A; Qian J; Soh HT; Daugherty PS; Lagally ET; Heeger AJ; Plaxco KW
J Am Chem Soc; 2010 Nov; 132(43):15299-307. PubMed ID: 20932008
[TBL] [Abstract][Full Text] [Related]
6. Assessment and quantification of telomerase enzyme activity.
Maritz MF; Richards LA; Mackenzie KL
Methods Mol Biol; 2013; 965():215-31. PubMed ID: 23296661
[TBL] [Abstract][Full Text] [Related]
7. Non-radioactive assay methods for the assessment of telomerase activity and telomere length.
Banerjee PP; Jagadeesh S
Methods Mol Biol; 2015; 1288():305-16. PubMed ID: 25827887
[TBL] [Abstract][Full Text] [Related]
8. [Telomerase activity in stool of patients with colorectal cancer].
Luo C; Zhao D; Qu J
Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):580-2. PubMed ID: 11758190
[TBL] [Abstract][Full Text] [Related]
9. Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
Gomez D; Mergny JL; Riou JF
Cancer Res; 2002 Jun; 62(12):3365-8. PubMed ID: 12067975
[TBL] [Abstract][Full Text] [Related]
10. Comparison of NCL-hTERT antibody reactivity and telomere repeat amplification protocol in situ in effusions.
Zendehrokh N; Rehnberg J; Dejmek A
Acta Cytol; 2007; 51(6):886-92. PubMed ID: 18077981
[TBL] [Abstract][Full Text] [Related]
11. Simplified method for the telomeric repeat amplification protocol (TRAP).
Sellner LN; Lock PM; Turbett GR
Biotechniques; 1998 May; 24(5):726-8. PubMed ID: 9591115
[No Abstract] [Full Text] [Related]
12. Telomeres and telomerase in the clinical management of colorectal cancer.
Piñol-Felis C; Fernández-Marcelo T; Viñas-Salas J; Valls-Bautista C
Clin Transl Oncol; 2017 Apr; 19(4):399-408. PubMed ID: 27761787
[TBL] [Abstract][Full Text] [Related]
13. Polymerase chain reaction-based enzyme immunoassay for quantitation of telomerase activity: application to colorectal cancers.
Cheng AJ; Tang R; Wang JY; Chang JT; Wang TC
Jpn J Cancer Res; 1999 Mar; 90(3):280-5. PubMed ID: 10359042
[TBL] [Abstract][Full Text] [Related]
14. [Telomerase and cancer: importance of detection of telomerase activity in pathology].
Brousset P
Ann Pathol; 1998 Nov; 18(5):375-6. PubMed ID: 9864572
[No Abstract] [Full Text] [Related]
15. A quantitative method to measure telomerase activity by bioluminescence connected with telomeric repeat amplification protocol.
Xu S; He M; Yu H; Cai X; Tan X; Lu B; Shu B
Anal Biochem; 2001 Dec; 299(2):188-93. PubMed ID: 11730342
[TBL] [Abstract][Full Text] [Related]
16. Increased sensitivity and reproducibility of TRAP assay by avoiding direct primers interaction.
Falchetti ML; Levi A; Molinari P; Verna R; D'Ambrosio E
Nucleic Acids Res; 1998 Feb; 26(3):862-3. PubMed ID: 9443983
[TBL] [Abstract][Full Text] [Related]
17. Prompt activation of telomerase by chemical carcinogens in rats detected with a modified TRAP assay.
Miura M; Karasaki Y; Abe T; Higashi K; Ikemura K; Gotoh S
Biochem Biophys Res Commun; 1998 May; 246(1):13-9. PubMed ID: 9600060
[TBL] [Abstract][Full Text] [Related]
18. [Quantitation of telomerase activity using the polymerase chain reaction-based enzyme immunoassay and its clinical application].
Chen WQ; Chen HM; Hu YJ
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):221-3. PubMed ID: 12575296
[TBL] [Abstract][Full Text] [Related]
19. Correlative polymorphism of NAD(P)H: quinone oxidoreductase (NQO1) with telomere shortening in colorectal cancer.
Takagi S; Kinouchi Y; Hiwatashi N; Hirai M; Suzuki S; Takahashi S; Negoro K; Obana N; Shimosegawa T
Anticancer Res; 2002; 22(5):2749-52. PubMed ID: 12529991
[TBL] [Abstract][Full Text] [Related]
20. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
